Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue)—100

Sarcoma, soft tissue (of muscle, fat, or fibrous connective tissue) 

Soft tissue sarcoma refers to a broad category of malignant tumors that develop in the soft tissues of the body, including muscle, fat, or fibrous connective tissue. These tumors arise from abnormal growth of cells in these tissues and can occur in various locations throughout the body. Soft tissue sarcomas are relatively rare and can have different subtypes based on the specific tissue of origin.

Causes 

The causes of soft tissue sarcoma are:

  • Genetic mutations or abnormalities in the DNA of soft tissue cells.
  • Exposure to certain environmental factors or carcinogens.
  • Inherited genetic syndromes, such as Li-Fraumeni syndrome, neurofibromatosis, or hereditary retinoblastoma.
  • Previous radiation therapy to the affected area.
  • Certain viral infections, such as human herpesvirus-8 (HHV-8) or human immunodeficiency virus (HIV).

Symptoms

Here are some symptoms of soft tissue sarcoma:

  • Palpable mass or lump in the affected area.
  • Pain or tenderness at the site of the tumor.
  • Limited range of motion or stiffness.
  • Swelling or enlargement of the affected area.
  • Weakness or loss of function in nearby muscles or limbs.
  • Fatigue or unexplained weight loss.
  • Fever or night sweats in some cases.

Diagnosis 

Diagnosis of soft tissue sarcoma is made through the following tests and exams:

  • Physical examination to evaluate symptoms and identify any palpable masses or abnormalities.
  • Imaging tests, such as MRI, CT scan, or ultrasound, to visualize the tumor and assess its size, location, and involvement with nearby structures.
  • Biopsy of the tumor for histopathological examination, which helps confirm the presence of sarcoma cells and determine the specific subtype and grade of the tumor.
  • Blood tests to assess overall health and identify any abnormalities that may be associated with the tumor.
  • Additional tests, such as PET scan, bone scan, or molecular testing, may be performed to determine the extent of the disease, evaluate metastasis, and guide treatment decisions.
  • Staging of the tumor to determine the extent of its spread and help plan appropriate treatment approaches.

Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of three or more features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with six or more characteristics of disfigurement

80
Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of two features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with four or five characteristics of disfigurement

50
Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of one feature or paired set of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with two or three characteristics of disfigurement

30
Description Percentage

With one characteristic of disfigurement

10

Note (1): The 8 characteristics of disfigurement, for purposes of evaluation under §4.118, are:

Scar 5 or more inches (13 or more cm.) in length. Scar at least one-quarter inch (0.6 cm.) wide at widest part.

Surface contour of scar elevated or depressed on palpation.

Scar adherent to underlying tissue.

Skin hypo-or hyper-pigmented in an area exceeding six square inches (39 sq. cm.).

Skin texture abnormal (irregular, atrophic, shiny, scaly, etc.) in

an area exceeding six square inches (39 sq. cm.).

Underlying soft tissue missing in an area exceeding six square inches (39 sq. cm.).

Skin indurated and inflexible in an area exceeding six square inches (39 sq. cm.).

 

Note (2): Rate tissue loss of the auricle under DC 6207 (loss of auricle) and anatomical loss of the eye under DC 6061 (anatomical loss of both eyes) or DC 6063 (anatomical loss of one eye), as appropriate.

Note (3): Take into consideration unretouched color photographs when evaluating under these criteria.

Note (4): Separately evaluate disabling effects other than disfigurement that are associated with individual scar(s) of the head, face, or neck, such as pain, instability, and residuals of associated muscle or nerve injury, under the appropriate diagnostic code(s) and apply § 4.25 to combine the evaluation(s) with the evaluation assigned under this diagnostic code.

Note (5): The characteristic(s) of disfigurement may be caused by one scar or by multiple scars; the characteristic(s) required to assign a particular evaluation need not be caused by a single scar in order to assign that evaluation.

Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of three or more features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with six or more characteristics of disfigurement

80

Need help with Medical Compensation? If your disability claim is not clearly supported by your medical records along with evidence, your claim can be denied. We have helped thousands of Veterans claim the compensation they deserve.

Get More Info